Oxford BioMedica (OTCMKTS:OXBDF - Get Free Report) traded up 6.1% during trading on Thursday . The stock traded as high as $7.80 and last traded at $7.80. 20,000 shares changed hands during mid-day trading, an increase of 57,207% from the average session volume of 35 shares. The stock had previously closed at $7.35.
Oxford BioMedica Stock Up 6.3%
The company has a 50 day moving average of $6.49 and a 200 day moving average of $4.87.
About Oxford BioMedica
(
Get Free Report)
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
Further Reading
Before you consider Oxford BioMedica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford BioMedica wasn't on the list.
While Oxford BioMedica currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
